Integrity Alliance’s AstraZeneca AZN Stock Holding History

Integrity Alliance’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$374K	Sell	1,977 -372	-16%	-$70K	0.01%	595
2026 Q1	$462K	Sell	2,349 -1,122	-32%	-$216K	0.02%	466
2025 Q4	$638K	Sell	3,471 -422	-11%	-$74K	0.02%	401
2025 Q3	$597K	Buy	3,893 +1,483	+62%	+$224K	0.03%	323
2025 Q2	$337K	Sell	2,410 -581	-19%	-$81.4K	0.02%	366
2025 Q1	$440K	Buy	+2,991	New	+$433K	0.02%	405

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Integrity Alliance's AZN Position: Q2 2026 in Review

Integrity Alliance reduced its AstraZeneca (AZN) stake by 16% in Q2 2026, selling an estimated $70K and leaving 1,977 shares worth $374K. The position accounts for 0.01% of the portfolio, ranked #595.

Integrity Alliance first reported a position in AZN in Q1 2025 and has held it in 6 quarters since. The position peaked at $638K in Q4 2025. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Integrity Alliance held 1,977 shares of AstraZeneca worth $374K as of Q2 2026.
Integrity Alliance sold 372 AstraZeneca shares in Q2 2026, an estimated $70K.
AstraZeneca made up 0.01% of Integrity Alliance's portfolio in Q2 2026, its #595 holding.
Integrity Alliance first reported a position in AstraZeneca in Q1 2025 and has held it in 6 quarters since.
Integrity Alliance's AstraZeneca position peaked at $638K in Q4 2025.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Integrity Alliance's 13F filing for Q2 2026, filed 31 Jul 2026.